APO RESEARCH · REPORT
Positron Emission Tomography (PET)
PET scanner is a type of nuclear medicine imaging. The scan uses a special dye that has radioactive tracers.
Product & engineering
Understand the product.
PET scanner is a type of nuclear medicine imaging. The scan uses a special dye that has radioactive tracers.
Positron-emission tomography (PET) is a nuclear medicine functional imaging technique that is used to observe metabolic processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer), which is introduced into the body on a biologically active molecule. Three-dimensional images of tracer concentration within the body are then constructed by computer analysis. In modern PET-CT scanners, three-dimensional imaging is often accomplished with the aid of a CT X-ray scan performed on the patient during the same session, in the same machine.
Selected research
Industry Research
Positron Emission Tomography (PET) Industry Research Report 2026
Market perspective
PET scanner is a type of nuclear medicine imaging. The scan uses a special dye that has radioactive tracers.
Positron-emission tomography (PET) is a nuclear medicine functional imaging technique that is used to observe metabolic processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer), which is introduced into the body on a biologically active molecule. Three-dimensional images of tracer concentration within the body are then constructed by computer analysis. In modern PET-CT scanners, three-dimensional imaging is often accomplished with the aid of a CT X-ray scan performed on the patient during the same session, in the same machine.
Market competition is intense. GE, Siemens Healthcare, Philips Healthcare are the leaders of the industry. The clear market leader is GE, which holds a 37% market share. In second place is Siemens Healthcare with a 31% market share, while Philips Healthcare has a strong presence in the market.
Read the full market overview
North America is the largest sales place, with a sales market share nearly 50%. Following USA, Europe is the second largest sales place with the sales market share of 23%.
Report Scope
This report quantifies the global Positron Emission Tomography (PET) market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Positron Emission Tomography (PET) Market by Company
GE
Siemens Healthcare
Philips Healthcare
Toshiba
Hitachi
Neusoft
Topgrade HealthCare
United Imaging
Positron Emission Tomography (PET) Segment by Type
PET-CT
PET-MR
Others
Positron Emission Tomography (PET) Segment by Application
Oncology
Cardiology
Neurology
Others
Positron Emission Tomography (PET) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Positron Emission Tomography (PET) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Positron Emission Tomography (PET) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Positron Emission Tomography (PET).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Positron Emission Tomography (PET) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Positron Emission Tomography (PET) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Positron Emission Tomography (PET) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- PET-CT
- PET-MR
- Others
Applications
- Oncology
- Cardiology
- Neurology
- Others
Companies covered
- GE
- Siemens Healthcare
- Philips Healthcare
- Toshiba
- Hitachi
- Neusoft
- Topgrade HealthCare
- United Imaging
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Positron Emission Tomography (PET) Market Size (2021-2032)
- 2.2.2 Global Positron Emission Tomography (PET) Sales (2021-2032)
- 2.2.3 Global Positron Emission Tomography (PET) Market Average Price (2021-2032)
- 2.3 Positron Emission Tomography (PET) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 PET-CT
- 2.3.3 PET-MR
- 2.3.4 Others
- 2.4 Positron Emission Tomography (PET) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Oncology
- 2.4.3 Cardiology
- 2.4.4 Neurology
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Positron Emission Tomography (PET) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Positron Emission Tomography (PET) Sales (Units) of Manufacturers (2021-2026)
- 3.3 Global Positron Emission Tomography (PET) Revenue of Manufacturers (2021-2026)
- 3.4 Global Positron Emission Tomography (PET) Average Price by Manufacturers (2021-2026)
- 3.5 Global Positron Emission Tomography (PET) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Positron Emission Tomography (PET), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Positron Emission Tomography (PET), Product Type & Application
- 3.8 Global Manufacturers of Positron Emission Tomography (PET), Established Date
- 3.9 Global Positron Emission Tomography (PET) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 GE
- 4.1.1 GE Company Information
- 4.1.2 GE Business Overview
- 4.1.3 GE Positron Emission Tomography (PET) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 GE Positron Emission Tomography (PET) Product Portfolio
- 4.1.5 GE Recent Developments
- 4.2 Siemens Healthcare
- 4.2.1 Siemens Healthcare Company Information
- 4.2.2 Siemens Healthcare Business Overview
- 4.2.3 Siemens Healthcare Positron Emission Tomography (PET) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Siemens Healthcare Positron Emission Tomography (PET) Product Portfolio
- 4.2.5 Siemens Healthcare Recent Developments
- 4.3 Philips Healthcare
- 4.3.1 Philips Healthcare Company Information
- 4.3.2 Philips Healthcare Business Overview
- 4.3.3 Philips Healthcare Positron Emission Tomography (PET) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Philips Healthcare Positron Emission Tomography (PET) Product Portfolio
- 4.3.5 Philips Healthcare Recent Developments
- 4.4 Toshiba
- 4.4.1 Toshiba Company Information
- 4.4.2 Toshiba Business Overview
- 4.4.3 Toshiba Positron Emission Tomography (PET) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Toshiba Positron Emission Tomography (PET) Product Portfolio
- 4.4.5 Toshiba Recent Developments
- 4.5 Hitachi
- 4.5.1 Hitachi Company Information
- 4.5.2 Hitachi Business Overview
- 4.5.3 Hitachi Positron Emission Tomography (PET) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hitachi Positron Emission Tomography (PET) Product Portfolio
- 4.5.5 Hitachi Recent Developments
- 4.6 Neusoft
- 4.6.1 Neusoft Company Information
- 4.6.2 Neusoft Business Overview
- 4.6.3 Neusoft Positron Emission Tomography (PET) Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Neusoft Positron Emission Tomography (PET) Product Portfolio
- 4.6.5 Neusoft Recent Developments
- 4.7 Topgrade HealthCare
- 4.7.1 Topgrade HealthCare Company Information
- 4.7.2 Topgrade HealthCare Business Overview
- 4.7.3 Topgrade HealthCare Positron Emission Tomography (PET) Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Topgrade HealthCare Positron Emission Tomography (PET) Product Portfolio
- 4.7.5 Topgrade HealthCare Recent Developments
- 4.8 United Imaging
- 4.8.1 United Imaging Company Information
- 4.8.2 United Imaging Business Overview
- 4.8.3 United Imaging Positron Emission Tomography (PET) Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 United Imaging Positron Emission Tomography (PET) Product Portfolio
- 4.8.5 United Imaging Recent Developments
5 Global Positron Emission Tomography (PET) Market Scenario by Region
- 5.1 Global Positron Emission Tomography (PET) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Positron Emission Tomography (PET) Sales by Region: 2021-2032
- 5.2.1 Global Positron Emission Tomography (PET) Sales by Region: 2021-2026
- 5.2.2 Global Positron Emission Tomography (PET) Sales by Region: 2027-2032
- 5.3 Global Positron Emission Tomography (PET) Revenue by Region: 2021-2032
- 5.3.1 Global Positron Emission Tomography (PET) Revenue by Region: 2021-2026
- 5.3.2 Global Positron Emission Tomography (PET) Revenue by Region: 2027-2032
- 5.4 North America Positron Emission Tomography (PET) Market Facts & Figures by Country
- 5.4.1 North America Positron Emission Tomography (PET) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Positron Emission Tomography (PET) Sales by Country (2021-2032)
- 5.4.3 North America Positron Emission Tomography (PET) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Positron Emission Tomography (PET) Market Facts & Figures by Country
- 5.5.1 Europe Positron Emission Tomography (PET) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Positron Emission Tomography (PET) Sales by Country (2021-2032)
- 5.5.3 Europe Positron Emission Tomography (PET) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Positron Emission Tomography (PET) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Positron Emission Tomography (PET) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Positron Emission Tomography (PET) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Positron Emission Tomography (PET) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Positron Emission Tomography (PET) Market Facts & Figures by Country
- 5.7.1 South America Positron Emission Tomography (PET) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Positron Emission Tomography (PET) Sales by Country (2021-2032)
- 5.7.3 South America Positron Emission Tomography (PET) Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Positron Emission Tomography (PET) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Positron Emission Tomography (PET) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Positron Emission Tomography (PET) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Positron Emission Tomography (PET) Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Positron Emission Tomography (PET) Sales by Type (2021-2032)
- 6.1.1 Global Positron Emission Tomography (PET) Sales by Type (2021-2032) & (Units)
- 6.1.2 Global Positron Emission Tomography (PET) Sales Market Share by Type (2021-2032)
- 6.2 Global Positron Emission Tomography (PET) Revenue by Type (2021-2032)
- 6.2.1 Global Positron Emission Tomography (PET) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Positron Emission Tomography (PET) Revenue Market Share by Type (2021-2032)
- 6.3 Global Positron Emission Tomography (PET) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Positron Emission Tomography (PET) Sales by Application (2021-2032)
- 7.1.1 Global Positron Emission Tomography (PET) Sales by Application (2021-2032) & (Units)
- 7.1.2 Global Positron Emission Tomography (PET) Sales Market Share by Application (2021-2032)
- 7.2 Global Positron Emission Tomography (PET) Revenue by Application (2021-2032)
- 7.2.1 Global Positron Emission Tomography (PET) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Positron Emission Tomography (PET) Revenue Market Share by Application (2021-2032)
- 7.3 Global Positron Emission Tomography (PET) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Positron Emission Tomography (PET) Value Chain Analysis
- 8.1.1 Positron Emission Tomography (PET) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Positron Emission Tomography (PET) Production Mode & Process
- 8.2 Positron Emission Tomography (PET) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Positron Emission Tomography (PET) Distributors
- 8.2.3 Positron Emission Tomography (PET) Customers
9 Global Positron Emission Tomography (PET) Analyzing Market Dynamics
- 9.1 Positron Emission Tomography (PET) Industry Trends
- 9.2 Positron Emission Tomography (PET) Industry Drivers
- 9.3 Positron Emission Tomography (PET) Industry Opportunities and Challenges
- 9.4 Positron Emission Tomography (PET) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst